HEADER TRANSFERASE/INHIBITOR 23-NOV-20 7KSK TITLE THIOPHENYL-PYRAZOLOUREA DERIVATIVES AS POTENT, BRIAN PENETRANT, ORALLY TITLE 2 BIOAVAILABLE, AND ISOFORM-SELECTIVE JNK3 INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 10; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPK 10,MAP KINASE P49 3F12,STRESS-ACTIVATED PROTEIN KINASE COMPND 5 1B,SAPK1B,STRESS-ACTIVATED PROTEIN KINASE JNK3,C-JUN N-TERMINAL COMPND 6 KINASE 3; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK10, JNK3, JNK3A, PRKM10, SAPK1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS JNK3, KINASE INHIBITOR, ALZHEIMER DISEASE, PYRAZOLOUREA, KEYWDS 2 NEURODEGENERATION, TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.PARK REVDAT 2 18-OCT-23 7KSK 1 REMARK REVDAT 1 03-MAR-21 7KSK 0 JRNL AUTH Y.FENG,H.PARK,L.BAUER,J.C.RYU,S.O.YOON JRNL TITL THIOPHENE-PYRAZOLOUREA DERIVATIVES AS POTENT, ORALLY JRNL TITL 2 BIOAVAILABLE, AND ISOFORM-SELECTIVE JNK3 INHIBITORS. JRNL REF ACS MED.CHEM.LETT. V. 12 24 2021 JRNL REFN ISSN 1948-5875 JRNL PMID 33488960 JRNL DOI 10.1021/ACSMEDCHEMLETT.0C00533 REMARK 2 REMARK 2 RESOLUTION. 1.84 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_3965 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.84 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 53.80 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 86.9 REMARK 3 NUMBER OF REFLECTIONS : 31116 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.249 REMARK 3 R VALUE (WORKING SET) : 0.247 REMARK 3 FREE R VALUE : 0.290 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1558 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 53.8000 - 4.0800 0.95 3134 169 0.1966 0.2198 REMARK 3 2 4.0800 - 3.2400 0.73 2297 113 0.2145 0.2983 REMARK 3 3 3.2400 - 2.8300 0.98 3063 161 0.2528 0.2845 REMARK 3 4 2.8300 - 2.5700 0.50 1545 95 0.2582 0.2968 REMARK 3 5 2.5700 - 2.3900 0.98 3004 138 0.2451 0.3010 REMARK 3 6 2.3900 - 2.2500 0.96 2951 171 0.2768 0.2765 REMARK 3 7 2.2500 - 2.1300 0.98 2988 153 0.2803 0.3604 REMARK 3 8 2.1300 - 2.0400 0.94 2881 146 0.3140 0.4058 REMARK 3 9 2.0400 - 1.9600 0.98 3001 154 0.3408 0.3458 REMARK 3 10 1.9600 - 1.9000 0.90 2715 163 0.4286 0.4970 REMARK 3 11 1.8700 - 1.8400 0.96 1979 95 0.4184 0.4668 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.270 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 38.110 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.18 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7KSK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-NOV-20. REMARK 100 THE DEPOSITION ID IS D_1000253103. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-SEP-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97872 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31286 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.836 REMARK 200 RESOLUTION RANGE LOW (A) : 53.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.4 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.84 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.87 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1JNK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM TARTRATE PH 7.0, 20 % REMARK 280 PEG 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.06850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.79950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.61200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.79950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.06850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.61200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 LEU A 3 REMARK 465 HIS A 4 REMARK 465 PHE A 5 REMARK 465 LEU A 6 REMARK 465 TYR A 7 REMARK 465 TYR A 8 REMARK 465 CYS A 9 REMARK 465 SER A 10 REMARK 465 GLU A 11 REMARK 465 PRO A 12 REMARK 465 THR A 13 REMARK 465 LEU A 14 REMARK 465 ASP A 15 REMARK 465 VAL A 16 REMARK 465 LYS A 17 REMARK 465 ILE A 18 REMARK 465 ALA A 19 REMARK 465 PHE A 20 REMARK 465 CYS A 21 REMARK 465 GLN A 22 REMARK 465 GLY A 23 REMARK 465 PHE A 24 REMARK 465 ASP A 25 REMARK 465 LYS A 26 REMARK 465 GLN A 27 REMARK 465 VAL A 28 REMARK 465 ASP A 29 REMARK 465 VAL A 30 REMARK 465 SER A 31 REMARK 465 TYR A 32 REMARK 465 ILE A 33 REMARK 465 ALA A 34 REMARK 465 LYS A 35 REMARK 465 HIS A 36 REMARK 465 TYR A 37 REMARK 465 ASN A 38 REMARK 465 MET A 39 REMARK 465 SER A 40 REMARK 465 LYS A 41 REMARK 465 SER A 42 REMARK 465 LYS A 43 REMARK 465 VAL A 44 REMARK 465 GLY A 54 REMARK 465 GLY A 73 REMARK 465 ALA A 74 REMARK 465 GLN A 75 REMARK 465 ARG A 212 REMARK 465 THR A 213 REMARK 465 ALA A 214 REMARK 465 GLY A 215 REMARK 465 THR A 216 REMARK 465 TYR A 223 REMARK 465 ALA A 320 REMARK 465 TYR A 363 REMARK 465 VAL A 368 REMARK 465 ALA A 370 REMARK 465 PRO A 371 REMARK 465 PRO A 372 REMARK 465 PRO A 373 REMARK 465 GLN A 374 REMARK 465 ILE A 375 REMARK 465 TYR A 376 REMARK 465 ASP A 377 REMARK 465 LYS A 378 REMARK 465 SER A 401 REMARK 465 GLU A 402 REMARK 465 GLU A 403 REMARK 465 LYS A 404 REMARK 465 THR A 405 REMARK 465 LYS A 406 REMARK 465 ASN A 407 REMARK 465 GLY A 408 REMARK 465 VAL A 409 REMARK 465 VAL A 410 REMARK 465 LYS A 411 REMARK 465 GLY A 412 REMARK 465 GLN A 413 REMARK 465 PRO A 414 REMARK 465 SER A 415 REMARK 465 PRO A 416 REMARK 465 SER A 417 REMARK 465 GLY A 418 REMARK 465 ALA A 419 REMARK 465 ALA A 420 REMARK 465 VAL A 421 REMARK 465 ASN A 422 REMARK 465 SER A 423 REMARK 465 SER A 424 REMARK 465 GLU A 425 REMARK 465 SER A 426 REMARK 465 LEU A 427 REMARK 465 PRO A 428 REMARK 465 PRO A 429 REMARK 465 SER A 430 REMARK 465 SER A 431 REMARK 465 SER A 432 REMARK 465 VAL A 433 REMARK 465 ASN A 434 REMARK 465 ASP A 435 REMARK 465 ILE A 436 REMARK 465 SER A 437 REMARK 465 SER A 438 REMARK 465 MET A 439 REMARK 465 SER A 440 REMARK 465 THR A 441 REMARK 465 ASP A 442 REMARK 465 GLN A 443 REMARK 465 THR A 444 REMARK 465 LEU A 445 REMARK 465 ALA A 446 REMARK 465 SER A 447 REMARK 465 ASP A 448 REMARK 465 THR A 449 REMARK 465 ASP A 450 REMARK 465 SER A 451 REMARK 465 SER A 452 REMARK 465 LEU A 453 REMARK 465 GLU A 454 REMARK 465 ALA A 455 REMARK 465 SER A 456 REMARK 465 ALA A 457 REMARK 465 GLY A 458 REMARK 465 PRO A 459 REMARK 465 LEU A 460 REMARK 465 GLY A 461 REMARK 465 CYS A 462 REMARK 465 CYS A 463 REMARK 465 ARG A 464 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 285 CG CD OE1 OE2 REMARK 470 GLN A 379 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 140 -52.35 -137.91 REMARK 500 MET A 149 -166.14 -100.22 REMARK 500 ARG A 188 -4.88 75.99 REMARK 500 ASP A 189 42.19 -141.63 REMARK 500 CYS A 201 4.85 80.62 REMARK 500 PHE A 218 130.26 170.83 REMARK 500 ASP A 381 126.84 -38.20 REMARK 500 ARG A 383 -167.01 -79.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue X3V A 1101 DBREF 7KSK A 1 464 UNP P53779 MK10_HUMAN 1 464 SEQRES 1 A 464 MET SER LEU HIS PHE LEU TYR TYR CYS SER GLU PRO THR SEQRES 2 A 464 LEU ASP VAL LYS ILE ALA PHE CYS GLN GLY PHE ASP LYS SEQRES 3 A 464 GLN VAL ASP VAL SER TYR ILE ALA LYS HIS TYR ASN MET SEQRES 4 A 464 SER LYS SER LYS VAL ASP ASN GLN PHE TYR SER VAL GLU SEQRES 5 A 464 VAL GLY ASP SER THR PHE THR VAL LEU LYS ARG TYR GLN SEQRES 6 A 464 ASN LEU LYS PRO ILE GLY SER GLY ALA GLN GLY ILE VAL SEQRES 7 A 464 CYS ALA ALA TYR ASP ALA VAL LEU ASP ARG ASN VAL ALA SEQRES 8 A 464 ILE LYS LYS LEU SER ARG PRO PHE GLN ASN GLN THR HIS SEQRES 9 A 464 ALA LYS ARG ALA TYR ARG GLU LEU VAL LEU MET LYS CYS SEQRES 10 A 464 VAL ASN HIS LYS ASN ILE ILE SER LEU LEU ASN VAL PHE SEQRES 11 A 464 THR PRO GLN LYS THR LEU GLU GLU PHE GLN ASP VAL TYR SEQRES 12 A 464 LEU VAL MET GLU LEU MET ASP ALA ASN LEU CYS GLN VAL SEQRES 13 A 464 ILE GLN MET GLU LEU ASP HIS GLU ARG MET SER TYR LEU SEQRES 14 A 464 LEU TYR GLN MET LEU CYS GLY ILE LYS HIS LEU HIS SER SEQRES 15 A 464 ALA GLY ILE ILE HIS ARG ASP LEU LYS PRO SER ASN ILE SEQRES 16 A 464 VAL VAL LYS SER ASP CYS THR LEU LYS ILE LEU ASP PHE SEQRES 17 A 464 GLY LEU ALA ARG THR ALA GLY THR SER PHE MET MET THR SEQRES 18 A 464 PRO TYR VAL VAL THR ARG TYR TYR ARG ALA PRO GLU VAL SEQRES 19 A 464 ILE LEU GLY MET GLY TYR LYS GLU ASN VAL ASP ILE TRP SEQRES 20 A 464 SER VAL GLY CYS ILE MET GLY GLU MET VAL ARG HIS LYS SEQRES 21 A 464 ILE LEU PHE PRO GLY ARG ASP TYR ILE ASP GLN TRP ASN SEQRES 22 A 464 LYS VAL ILE GLU GLN LEU GLY THR PRO CYS PRO GLU PHE SEQRES 23 A 464 MET LYS LYS LEU GLN PRO THR VAL ARG ASN TYR VAL GLU SEQRES 24 A 464 ASN ARG PRO LYS TYR ALA GLY LEU THR PHE PRO LYS LEU SEQRES 25 A 464 PHE PRO ASP SER LEU PHE PRO ALA ASP SER GLU HIS ASN SEQRES 26 A 464 LYS LEU LYS ALA SER GLN ALA ARG ASP LEU LEU SER LYS SEQRES 27 A 464 MET LEU VAL ILE ASP PRO ALA LYS ARG ILE SER VAL ASP SEQRES 28 A 464 ASP ALA LEU GLN HIS PRO TYR ILE ASN VAL TRP TYR ASP SEQRES 29 A 464 PRO ALA GLU VAL GLU ALA PRO PRO PRO GLN ILE TYR ASP SEQRES 30 A 464 LYS GLN LEU ASP GLU ARG GLU HIS THR ILE GLU GLU TRP SEQRES 31 A 464 LYS GLU LEU ILE TYR LYS GLU VAL MET ASN SER GLU GLU SEQRES 32 A 464 LYS THR LYS ASN GLY VAL VAL LYS GLY GLN PRO SER PRO SEQRES 33 A 464 SER GLY ALA ALA VAL ASN SER SER GLU SER LEU PRO PRO SEQRES 34 A 464 SER SER SER VAL ASN ASP ILE SER SER MET SER THR ASP SEQRES 35 A 464 GLN THR LEU ALA SER ASP THR ASP SER SER LEU GLU ALA SEQRES 36 A 464 SER ALA GLY PRO LEU GLY CYS CYS ARG HET X3V A1101 44 HETNAM X3V 4-(4-{[(2-CHLOROPHENYL)CARBAMOYL]AMINO}-1H-PYRAZOL-1- HETNAM 2 X3V YL)-N-(OXETAN-3-YL)THIOPHENE-2-CARBOXAMIDE FORMUL 2 X3V C18 H16 CL N5 O3 S FORMUL 3 HOH *53(H2 O) HELIX 1 AA1 ASN A 101 LYS A 116 1 16 HELIX 2 AA2 LEU A 153 GLN A 158 1 6 HELIX 3 AA3 ASP A 162 ALA A 183 1 22 HELIX 4 AA4 LYS A 191 SER A 193 5 3 HELIX 5 AA5 ALA A 231 GLY A 237 1 7 HELIX 6 AA6 ASN A 243 HIS A 259 1 17 HELIX 7 AA7 ASP A 267 GLY A 280 1 14 HELIX 8 AA8 CYS A 283 LYS A 288 1 6 HELIX 9 AA9 GLN A 291 ASN A 300 1 10 HELIX 10 AB1 THR A 308 PHE A 313 1 6 HELIX 11 AB2 PRO A 314 PHE A 318 5 5 HELIX 12 AB3 SER A 322 LEU A 340 1 19 HELIX 13 AB4 SER A 349 GLN A 355 1 7 HELIX 14 AB5 THR A 386 MET A 399 1 14 SHEET 1 AA1 2 PHE A 48 GLU A 52 0 SHEET 2 AA1 2 THR A 57 LEU A 61 -1 O PHE A 58 N VAL A 51 SHEET 1 AA2 5 TYR A 64 GLY A 71 0 SHEET 2 AA2 5 ILE A 77 ASP A 83 -1 O ALA A 80 N LYS A 68 SHEET 3 AA2 5 ARG A 88 SER A 96 -1 O ARG A 88 N ASP A 83 SHEET 4 AA2 5 ASP A 141 GLU A 147 -1 O LEU A 144 N LYS A 93 SHEET 5 AA2 5 ASN A 128 PHE A 130 -1 N PHE A 130 O TYR A 143 SHEET 1 AA3 3 ALA A 151 ASN A 152 0 SHEET 2 AA3 3 ILE A 195 VAL A 197 -1 O VAL A 197 N ALA A 151 SHEET 3 AA3 3 LEU A 203 ILE A 205 -1 O LYS A 204 N VAL A 196 SITE 1 AC1 9 ALA A 91 LYS A 93 ILE A 124 LEU A 144 SITE 2 AC1 9 MET A 146 MET A 149 ASP A 150 LEU A 206 SITE 3 AC1 9 HOH A1209 CRYST1 52.137 71.224 107.599 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019180 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014040 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009294 0.00000